SELVAS Healthcare, Inc. (KOSDAQ: 208370)

Market Cap	104.93B
Revenue (ttm)	29.27B
Net Income (ttm)	2.14B
Shares Out	25.72M
EPS (ttm)	83.09
PE Ratio	49.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	164,438
Open	4,260.00
Previous Close	4,435.00
Day's Range	4,250.00 - 4,380.00
52-Week Range	3,425.00 - 7,460.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 19, 2025

About SELVAS Healthcare

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1999 and ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 208370

Financial Performance

In 2023, SELVAS Healthcare's revenue was 29.81 billion, an increase of 7.68% compared to the previous year's 27.69 billion. Earnings were 5.17 billion, an increase of 83.79%.